AboutTeamInvestmentsNewsContact
AboutTeamInvestmentsNewsContact

Sweden Fidelio Capital Sturegatan 10 114 36 Stockholm

United Kingdom Fidelio Capital 14-16 Bruton Place London W1J 6LX

United States Fidelio Capital 250 West 55th Street, 17th Floor New York, NY 10019

IndicalacquiresAfosatoexpandintothecompanionanimalsector

Share

Linkedin

Email

Copy link

Indical has acquired Afosa GmbH, a leading provider of ELISA diagnostics products to the companion animal sector, based in Germany.

Indical has a strong diagnostics portfolio focused on production animals, which is built on more than twenty years of research and development of molecular and immunological testing solutions. Through the acquisition of Afosa, Indical broadens its product offering to also include a number of diagnostic kits for companion animals.

Morenews
logo
News
2026-09-24
KEYTO Group establishes home security as a new business vertical
KEYTO Group continues to broaden its home services offering with a new vertical in home security. The first company to be added is the Swedish company Säkra Larm.
logo
News
2026-09-23
Audria expands into the UK with Tandem Property
Audria, a tech-driven real estate-services platform, expands into the UK with the addition of Tandem Property. Tandem Property provides property and asset management solutions, and is the fifth company to join Audria, following Newsec, Novier, Sveaviken and Avy.
logo
News
2026-09-02
Audria strengthens its real estate services offering with the addition of Novier
Audria, which brings together leading real estate services companies with a focus on technology, AI and international growth, strengthens its offering with the addition of Novier.
logo
AboutTeamInvestmentsNewsContact
Privacy policyCookie policyTerms & conditionsSFDR StatementConflicts of Interest Policy

Sweden
Fidelio Capital
Sturegatan 10
114 36 Stockholm

United Kingdom
Fidelio Capital
14-16 Bruton Place
London W1J 6LX

United States
Fidelio Capital
250 West 55th Street, 17th Floor
New York, NY 10019

Copyright © 2024 Fidelio Capital All rights reserved.